Research

Mixed

A multimodal metabolic health intervention emphasizing therapeutic carbohydrate reduction (TCR) and intermittent fasting, supported by remote monitoring and coaching, produces robust 1-year weight loss (mean 15.5%) and significant medication deprescription in patients with obesity and type 2 diabetes.

If you have obesity or type 2 diabetes, consider a structured program that combines a low-carbohydrate diet (under 30g carbs/day) with remote health monitoring and coaching. This approach can lead to significant weight loss (around 15%) and may allow you to reduce or stop diabetes and blood pressure medications under medical supervision, potentially saving money and avoiding medication side effects.

ModerateSupportsMEDIUM confidence
The TOWARD approach represents a scalable metabolic health intervention that demonstrates robust improvements in weight while simultaneously allowing for deprescription leading to substantial cost savings.
Laura Buchanan et al. · Frontiers in Nutrition · 2025

Why this rating

Single-arm pilot study with self-selection bias and no formal control group, though compared to published GLP-1 trial data.

Source

TOWARD, a metabolic health intervention, demonstrates robust 1-year weight loss and cost-savings through deprescription

Laura Buchanan et al. · Frontiers in Nutrition · 2025

DOI 10.3389/fnut.2025.1548609

cohort · n=50Cited 7×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →